From May 28 to 30, the 62nd Spring Pharmaceutical Machine Expo was held in Qingdao World Expo City. With the theme of “Data empowerment, Accelerating Progress”, Siemens exhibited the latest automation and information technology of Siemens from four perspectives of digital enterprise, research and development, production and equipment, allowing the audience to have an in-depth understanding of the latest application of digital twinning, mechanism modeling and simulation, big data prediction based on AI, continuous manufacturing and many other innovative technologies in the pharmaceutical field.

As the world’s leading digital solutions provider, Siemens focuses on the development of the pharmaceutical industry and hopes to bring together all ends of the industrial chain to promote the high-quality development of the pharmaceutical industry. During the exhibition, Siemens entered into strategic cooperation with two outstanding local partners to explore the digital future of the pharmaceutical industry with our customers!

To create a one-stop comprehensive service for the biopharmaceutical industry

On the first day of the exhibition, Siemens Pharmaceutical Machinery exhibition booth ushered in trillion Hongjing Intelligent Technology (Shanghai) Co., LTD. (trillion intelligent). Trillion Intelligence has expertise and rich experience in the field of biopharmaceutical digitalization and intelligence in China. The two sides officially signed a strategic cooperation agreement to further strengthen cooperation in the field of biopharmaceutical. Siemens will provide digitization and automation system and platform services for Trillion Intelligent, helping it realize digitization, informatization and intellectualization of biopharmaceutical production process and management process.

As a pioneer of digital intelligent technology and services in the biopharmaceutical industry in China, Trillion Intelligent is committed to providing advanced process management and control software for the industry. Its digitalization and automation technologies have been widely used in the biopharmaceutical industry. Siemens has a long history of cooperation with Trillion Smart. In the past three years, Trillion Smart has provided excellent digital information services for COVID-19 vaccine companies, and was selected as the best digital partner of Siemens.

In the future, Siemens and Trillion Intelligent will strengthen joint innovation and cooperation in the pharmaceutical industry, especially in the field of biopharmaceutical and continuous manufacturing, expand business areas, lead the development of the industry, and provide one-stop comprehensive services to the majority of biopharmaceutical enterprises.

Speed up the process of digital transformation of pharmaceutical industry

On May 29, Siemens and Blun Biotechnology (Jiangsu) Co., LTD. (Blun) held a signing ceremony to announce the strategic cooperation. Siemens will be the preferred supplier of Bioautomation solutions to Bioautomation, providing project consulting and SIMICAS OEM equipment remote operation and maintenance suite solutions.

Biolun is a leading overall solution provider for biopharmaceutical engineering in China, focusing on the research and application of biopharmaceutical and bioengineering industries. It is able to complete the modular design, manufacturing and assembly integration of process system units according to customer requirements, and has rich experience in the integration and verification of large-scale process system equipment. Through this strategic cooperation, Siemens will give full play to its advantages in automation, digitalization and intelligence, and jointly promote the pharmaceutical industry to accelerate the process of digital transformation.

In the future, Blun will also cooperate with Siemens in the comprehensive solutions of domestic middle and high-end pharmaceutical enterprises, promote the promotion and implementation of Siemens MCD, MES, SIMICAS and other digital software and systems, and expand cooperation opportunities in food, beverage and other related industries.